Primary tabs

Cindy Xie

Her ongoing work is utilizing next generation sequencing technologies to discover liquid biopsy and cellular heterogeneity in patients with colon cancer or glioblastoma multiforme tumors. The new knowledge generated from this discovery will benefit noninvasive cancer diagnosis and monitor anti-cancer therapeutic response.

Selected publication:
1. Xie F, von Dadelszen P, Nadeau JN. CMV infection, TLR-2 and -4 expression and cytokine profiles in early-onset preeclampsia with HELLP syndrome. Am J Reprod Immunol. 2014 Apr;71(4):379-86.
2. Benton J, Hu Y, Xie F, Kupfer K, Lee SW, Magee L, von Dadelszen P. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. Feb, 2012, 163.e1–163.e7

3. Benton S, Hu Y, Xie F, Sheard P, Kupfer K, Magee L, von Dadelszen P. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays submission. Am J Obstet Gynecol. 2011 Jun 21.
4. Bollyky PL, Wu RP, Falk BA, Lord JD, Long SA, Preisinger A, Teng B, Holt GE, Standifer NE, Braun KR, Xie F, Samuels PL, Vernon RB, Gebe JA, Wight TN, Nepom GT. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7938-43. Epub 2011 Apr 25.
5. Xie F, von Dadelszen P. C. pneumoniae, CMV infection, and TLR signaling in preeclampsia complicated pregnancy. Academic Publishing GmbH & Co. KG, Germany. 2010.
6. Xie F, Hu Y, Peng G, Turvey S, von Dadelszen P. Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy. 2010; 29(4):390-8.

7. Xie F, Turvey SE, Mor G, Williams MA, von Dadelszen P. Toll-like receptor signaling and preeclampsia. Am J Reprod Immunol. 2010. 53:7-16.